Weekly Roundup: 14 Health Press Releases You Need to See
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
FDA warns users of popular weight-loss drugs to watch for counterfeits
Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.
Senators call on FDA to act against misleading weight-loss drug commercials
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out the advertisement of prescriptions for injectable weight-loss drugs without ...
Yahoo14d
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The drug, suzetrigine, received FDA approval on Thursday and will be available as a 50-milligram prescription ... its class to gain federal approval in over 20 years The approval of Journavx ...
Spectrum News NY114d
FDA approves painkiller designed to eliminate risk of addiction associated with opioids
It's the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter ... involves winning FDA approval for multiple ...
USA Today14d
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The drug, suzetrigine, received the FDA's official stamp of approval Thursday to be sold as a 50-milligram prescription pill taken every 12 hours, according to a press release. The medication will ...
U.S. News & World Report14d
FDA Approves First New Non-Opioid Pain Pill in Decades
FDA Approves First New Non-Opioid Pain Pill in ... While it provides a long-awaited alternative to opioids and over-the-counter painkillers like ibuprofen, research suggests its effectiveness ...
Cleveland.com14d
FDA approves new painkiller designed to avoid opioid addiction risk
It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter ... involves winning FDA approval for multiple ...
WNYT NewsChannel 1315d
FDA approves new nonopioid painkiller for acute pain
The FDA’s approval of Journavx marks what experts are calling a significant public health milestone. The drug is aimed at adults experiencing moderate to severe short-term pain and could offer ...
Healio15d
FDA approves nonopioid Journavx for moderate to severe acute pain
Perspective from Anita Gupta, DO, PharmD, MPP, GMP, FASA The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.
Healio15d
FDA approves third Actemra biosimilar; second available in intravenous, subcutaneous forms
The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.